Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Mahajan

Showing results (81-90 of 210) with videos related to

Pageof 21
Sort By:
Indian Journal of Dermatology, Venereology and Leprology|August 17, 2024
Flagellate-like presentation of Stevens-Johnson syndrome: Toxic epidermal necrolysis after gefitinib therapyKumari Sweta Leena Patra, Narayanan Baskaran, Debajyoti Chatterjee, et al.
Pediatric Dermatology|April 22, 2026
Unusual Cutaneous and Mucosal Manifestations of Neonatal Inflammatory Skin and Bowel Disease Type 1 due to a Novel Homozygous ADAM17 MutationKittu Malhi, Sukhdeep Singh, Pandiarajan Vignesh, et al.
Pflugers Archiv : European Journal of Physiology|February 4, 2016
The ICl,swell inhibitor DCPIB blocks Kir channels that possess weak affinity for PIP2Wu Deng, Rahul Mahajan, Clive M Baumgarten, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 16, 2019
Successful correction of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using full thickness skin graft in resource-poor settingsSatyaswarup Tripathy, Garima Dabas, Sanjeev Handa, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 15, 2023
Outcome of COVID-19 in patients with autoimmune bullous diseasesDipankar De, Raihan Ashraf, Hitaishi Mehta, et al.
Clinical and Experimental Dermatology|April 6, 2022
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigusNamrata Singh, Sanjeev Handa, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|September 19, 2025
Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohortSanjeev Handa, Anubha Dev, Anuradha Bishnoi, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 13, 2025
Non-pharmacological therapies and their efficacy in atopic dermatitis: A narrative reviewMude Hemalatha, Anubha Dev, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|January 20, 2023
Cross-sectional study to estimate the prevalence and risk factors of nonalcoholic fatty liver disease in children and adolescents with psoriasisRohit Panjiyar, Rahul Mahajan, Anmol Bhatia, et al.
Indian Journal of Dermatology|September 12, 2022
Evaluating the Effect of Supplementation with Bacillus clausii on Therapeutic Outcomes in Atopic Eczema-Results of an Observer-Blinded Parallel-Group Randomized Controlled StudyRicha Sharma, Sanjeev Handa, Rahul Mahajan, et al.
Pageof 21

Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
Indian Journal of Dermatology, Venereology and Leprology|August 17, 2024
Flagellate-like presentation of Stevens-Johnson syndrome: Toxic epidermal necrolysis after gefitinib therapyKumari Sweta Leena Patra, Narayanan Baskaran, Debajyoti Chatterjee, et al.
Pediatric Dermatology|April 22, 2026
Unusual Cutaneous and Mucosal Manifestations of Neonatal Inflammatory Skin and Bowel Disease Type 1 due to a Novel Homozygous ADAM17 MutationKittu Malhi, Sukhdeep Singh, Pandiarajan Vignesh, et al.
Pflugers Archiv : European Journal of Physiology|February 4, 2016
The ICl,swell inhibitor DCPIB blocks Kir channels that possess weak affinity for PIP2Wu Deng, Rahul Mahajan, Clive M Baumgarten, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 16, 2019
Successful correction of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using full thickness skin graft in resource-poor settingsSatyaswarup Tripathy, Garima Dabas, Sanjeev Handa, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 15, 2023
Outcome of COVID-19 in patients with autoimmune bullous diseasesDipankar De, Raihan Ashraf, Hitaishi Mehta, et al.
Clinical and Experimental Dermatology|April 6, 2022
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigusNamrata Singh, Sanjeev Handa, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|September 19, 2025
Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohortSanjeev Handa, Anubha Dev, Anuradha Bishnoi, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 13, 2025
Non-pharmacological therapies and their efficacy in atopic dermatitis: A narrative reviewMude Hemalatha, Anubha Dev, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|January 20, 2023
Cross-sectional study to estimate the prevalence and risk factors of nonalcoholic fatty liver disease in children and adolescents with psoriasisRohit Panjiyar, Rahul Mahajan, Anmol Bhatia, et al.
Indian Journal of Dermatology|September 12, 2022
Evaluating the Effect of Supplementation with Bacillus clausii on Therapeutic Outcomes in Atopic Eczema-Results of an Observer-Blinded Parallel-Group Randomized Controlled StudyRicha Sharma, Sanjeev Handa, Rahul Mahajan, et al.
Pageof 21